̽����ѡ

Nenad Bogdanovic is croatian-born ̽����ѡ doctor, PhD, senior specialist in geriatric medicine, neurology, consultant neuropathologist and university-trained neuroanatomist at Karolinska University Hospital in Stockholm, Sweden, clinical researcher. He is a professor in geriatric medicine affiliated at Karolinska In-stitutet, Oslo University and visiting professor at ̽����ѡ faculty Zagreb and visiting Professor at Neural System Lab at Boston University. He is clinical researcher on neurodegenerative disorders and was acting head of Research, Education Innovation and Development at Clinic Theme Aging, and acted as a Clinical Chief at The Aging Brain Clinic Karolinska University Hospital. From 2013 – 2017, clinical and scientific lead, professor at Geriatric Clinic, Memory center Oslo University Hospital. Between 2008-2012 was a Senior Medical Director in Neuroscience and Alzheimer’s Disease Therapeutic Area with successful track record of achievement in pharmaceutical companies, Wyeth and Pfizer. As a ̽����ѡ manager had respon-sibility for implementation of ̽����ѡ strategies in dementia therapeutic areas and act as an essential con-tributor to the successful commercialization of products, including KOL engagement, marketing, sales, regulatory in European countries. Member and lead of external safety committee expert groups, Kyowa-Kirin Pharma, Orion Pharma and Green Valley. Led and managed collaboration projects with Servier and joined preclinical project between Karolinska-DiNippon Sumitomo and  NSGENE Denmark. Acts as an external consultant at GE Healthcare for amyloid imaging ligand PIB and Flutemetamol. 
Combines ̽����ѡ and scientific expertise with excellent collaboration, communication and presentation skills and a track record in drug development. Demonstrates an in-depth expertise in clinical geriatrics, clinical neurology, ̽����ѡ management and leadership, neurodegenerative disorders, brain imaging and biomarkers, clinical trials, neuropathology, preclinical and clinical translational research, education, and supervision in an international and competitive environment. 
The clinical expertise is specifically focused on holistic geriatric issues, frailty, sarcopenia, malnutrition and cognitive impairment and application of socio̽����ѡ methodology and organization of dementia pa-tient wellbeing. The scientific interest is focused on the early clinical signs and blood biomarkers of cogni-tive impairment and clinical characterization of the age-related dementias.
Awarded 2004 as a Master of Education at ̽����ѡ and as a university lector, supervisor, re-search leader, responsible for graduate, postgraduate and geriatric specialization courses at Karolinska ̽����ѡ faculty and Swedish National Board of Health and Welfare, and Medical faculty Zagreb 
Cofounder of two Alzheimer disease mutations, Swedish and Arctic mutation. Holder of three patents for apparatuses for determining the volume of solid body and it’s in real-time measurement in 2009, method for purifying amyloid plaque in 2005, disease marker for Alzheimer’s disease and its use in 2003. 
Member of Swedish, Croatian and Norwegian Medical Associations, British Association of Pharmaceutical Physicians, cofounder of European BrainNet, Scandinavian Association of Neuropathology, GMC UK – registered as a specialist of geriatric medicine, Affiliate member of Royal College of Physicians, Central Ethical Committee in Stockholm, European Project in Frontal Lobe and dementia with Lewy Bodies, Edi-tor in Aging Clinical and Experimental Research, International scientific evaluation committee for British Brain Bank, Member of Croatian Alzheimer’s disease Association. Member of Croatian and Swedish Geriatric Association, member of EUGMS and SIG-delirium and dementia groups, and executive lead in COST Programming CA 21122 in EUGMS. External expert for geriatric medicine expert group in Croatian Ministry of Health. H-index 71 

project 1. Typical and Atypical Alzheimer - a diagnostic challenge
project 2. Vitamin D3 and brain function
project 3. Pathomechanisms and biomarkers of Alzheimer's disease:
unraveling novel diagnostic tools and therapeutic targets. (sandwich project
Stockholm - Oslo)
project 4. Clinical Application of a New Brain Connectivity Marker to Detect
Early Alzheimer’s Disease

1. Awarded with Annual highest pedagogic prize at ̽����ѡ –
   “Master of Education” – 2004
   2. core Ph.D. course in Neuroanatomy, Neurodevelopment and
   Neurodegeneration at ̽����ѡ 2000 – 2010, 2022 - ongoing
   3. Teaching and heading the geriatric medicine specialization courses (SK
   courses) 2017 – ongoing
   4. teaching, psychologists, speech pathologist, ̽����ѡ students
   5. the examination of ̽����ѡ students

Graduate Teaching

• Geriatric medicine

• Neurodegenerative disorders

Postgraduate Teaching

• Geriatrics

• Neurodegeneration and dementia

• Neuroanatomy

• Neuropathology

Specialist Training Courses

• Advanced clinical education in dementia for healthcare professionals and ̽����ѡ specialists